N/A
Average AnalystN/A
Top AnalystNeutral
Stock Target AdvisorN/A
Average UserUSD 0.11
0.00 (0.00)%
N/A
0.10M
USD -1.00
Based on the Bellevue Life Sciences Acquisition Corp. Rights stock forecast from 0 analysts, the average analyst target price for Bellevue Life Sciences Acquisition Corp. Rights is not available over the next 12 months. Bellevue Life Sciences Acquisition Corp. Rights’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bellevue Life Sciences Acquisition Corp. Rights is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Bellevue Life Sciences Acquisition Corp. Rights’s stock price was USD 0.11. Bellevue Life Sciences Acquisition Corp. Rights’s stock price has changed by -11.93% over the past week, -6.22% over the past month and -26.81% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|